Sanglifehrin−Cyclophilin Interaction: Degradation Work, Synthetic Macrocyclic Analogues, X-ray Crystal Structure, and Binding Data
Richard Sedrani(Novartis (Switzerland)), Jürgen Wagner(Vogtland-Klinik), Gerhard Zenke, Stefan Rohrbach(Novartis (Switzerland)), Dieter Wagner(Novartis (Switzerland)), Grety Rihs(Novartis (Switzerland)), Francesco Senia(Novartis (Switzerland)), Charles D. Papageorgiou(Novartis (Switzerland)), Lukas Oberer(Novartis (Switzerland)), L. M. MARTIN CABREJAS(Novartis (Switzerland)), Binh Thai(Novartis (Switzerland)), Anne-Marie Jutzi Eme(Novartis (Switzerland)), Julien France(Novartis (Switzerland)), Jörg Kallen(Novartis (Switzerland))
Cited by 113
Related Papers
Efficient Aldolase Catalytic Antibodies That Use the Enamine Mechanism of Natural Enzymes
|Science|1995|458
The Potent Protein Kinase C-Selective Inhibitor AEB071 (Sotrastaurin) Represents a New Class of Immunosuppressive Agents Affecting Early T-Cell Activation
|Journal of Pharmacology and Experimental Therapeutics|2009|160
Discovery of 3-(1<i>H</i>-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a Potent and Selective Inhibitor of Protein Kinase C Isotypes
|Journal of Medicinal Chemistry|2009|135
Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12C
|Cancer Discovery|2022|134
K<sub>2</sub>[Al<sub>12</sub><i>i</i>Bu<sub>12</sub>], a Compound with Al<sub>12</sub> Icosahedra
|Angewandte Chemie International Edition in English|1991|101